← All trials
NCT01474382
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2012
- Primary completion
- Aug 1, 2014
- Completion date
- Aug 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 150
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- SeptodontLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- University of California, San FranciscoOverall official - principal investigator
- Jean Brown ResearchOverall official - principal investigator
- Ohio State UniversityOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- University of PittsburghOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.